Lauterbach M

Institute for Advanced Diagnostics and Treatment, Sheppard Pratt Health System, Baltimore, Maryland.

3 papers

ArticlePsilocybin

Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal Ideation: An Open-Label Trial.

van der Vaart A, LaPratt J, Swartz K +5

Europe PMC2026
ArticlePsilocybin

Single-Dose Psilocybin for Depression With Severe Treatment Resistance: An Open-Label Trial.

Aaronson ST, van der Vaart A, Miller T +6

Europe PMC2025
ArticlePsilocybin

Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Open-Label Trial.

Aaronson ST, van der Vaart A, Miller T +6

Europe PMC2024